International Journal of General Medicine Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Development of a Vaccine to Prevent Japanese Encephalitis: a Brief Review

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Japanese Encephalitis Virus

  2014cited by this paper
• Japanese encephalitis

  2013cited by this paper
• Ecology and geographical expansion of Japanese encephalitis virus.

  2009cited by this paper
• Japanese Encephalitis Vaccine (Inactivated, Adsorbed) [IXIARO®]

  2009cited by this paper
• Vaccination for tropical mosquito borne encephalitis.

  2009cited by this paper
• IC51 Japanese Encephalitis vaccine

  2009cited by this paper
• Mosquito-borne diseases.

  2009cited by this paper
• Preventive strategies for frequent outbreaks of Japanese encephalitis in Northern India

  2008cited by this paper
• Japanese encephalitis vaccines – needs, flaws and achievements

  2008cited by this paper
• Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus

  2008cited by this paper
• Pathogenic flaviviruses.

  2008cited by this paper
• Emerging viral infections in South East Asia and the Pacific region

  2008cited by this paper
• Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004.

  2008cited by this paper
• Domestic Pigs and Japanese Encephalitis Virus Infection, Australia

  2008cited by this paper
• Emerging viral threats to the Australian blood supply

  2008cited by this paper
• Immune responses of recombinant adenoviruses expressing immunodominant epitopes against Japanese encephalitis virus.

  2008cited by this paper
• Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus

  2008cited by this paper
• Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice

  2007cited by this paper
• Chikungunya fever, falciparum malaria, dengue fever, Japanese encephalitis... are we listening to the warning signs for public health in India?

  2007cited by this paper
• Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line

  2007cited by this paper
• Vaccines for preventing Japanese encephalitis.

  2007cited by this paper
• Harnessing bioinformatics to discover new vaccines.

  2007cited by this paper
• Immunomics: discovering new targets for vaccines and therapeutics.

  2006cited by this paper
• The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.

  2006cited by this paper
• An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus

  2006cited by this paper
• Diagnostic methods for detection & isolation of dengue viruses from vector mosquitoes.

  2006cited by this paper
• Japanese encephalitis: development of new candidate vaccines

  2006cited by this paper
• Immunologic Analysis Induced by DNA Vaccine Encoding E Protein of Beijing-1 Strain Derived from Japanese Encephalitis Virus

  2006cited by this paper
• [Clinical and epidemiological aspects of Japanese encephalitis].

  2005cited by this paper
• Japanese encephalitis in Hong Kong.

  2005cited by this paper
• Host range, amplification and arboviral disease emergence.

  2005cited by this paper
• An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait

  2005cited by this paper
• A chimeric live attenuated vaccine against Japanese encephalitis

  2004cited by this paper
• Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.

  2004cited by this paper
• Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

  2003cited by this paper
• Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.

  2003cited by this paper
• [Encephalitis and psychosis].

  2003cited by this paper
• Exotic and emerging viral encephalitides.

  2003cited by this paper
• Allergic reactions to Japanese encephalitis vaccine.

  2003cited by this paper
• Recent advances in Japanese encephalitis

  2003cited by this paper
• Immunoinformatics--the new kid in town.

  2003cited by this paper
• Development of a recombinant vaccine against Japanese encephalitis

  2003cited by this paper
• Japanese encephalitis vaccines: moving away from the mouse brain

  2003cited by this paper
• Viral encephalitis: familiar infections and emerging pathogens.

  2002cited by this paper
• Emerging viral infections in Australia

  2002cited by this paper
• Invasions by insect vectors of human disease.

  2002cited by this paper
• Japanese encephalitis on Badu Island, Australia: the first isolation of Japanese encephalitis virus from Culex gelidus in the Australasian region and the role of mosquito host-feeding patterns in virus transmission cycles.

  2001cited by this paper
• Linking genomics to immunotherapy by reverse immunology--'immunomics' in the new millennium.

  2001cited by this paper
• Update on viral encephalitis

  2001cited by this paper
• Important unusual infections in Australia: a critical care perspective.

  2001cited by this paper
• Seizures in Japanese encephalitis.

  2001cited by this paper
• Heterogeneity in the host preference of Japanese encephalitis vectors in Chiang Mai, northern Thailand.

  2000cited by this paper
• Prognosis of Japanese encephalitis: a multivariate analysis.

  1998cited by this paper
• Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.

  1995cited by this paper
• Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area.

  1992cited by this paper
• An efficient method for production of purified inactivated Japanese encephalitis vaccine from mouse brains.

  1991cited by this paper
• [Transmission cycles of arboviruses in Madagascar].

  1989cited by this paper
• Control of Japanese encephalitis vectors.

  1989cited by this paper
• Protection against Japanese encephalitis by inactivated vaccines.

  1988cited by this paper
• [Inactivated vaccine against Japanese encephalitis. The characteristics of a purified preparation from mouse brain].

  1983cited by this paper
• Experimental studies on vertical infection of mice with Japanese encephalitis virus. IV. Effect of virus strain on placental and fetal infection.

  1983cited by this paper
• Large-scale purification of Japanese encephalitis virus from infected mouse brain for preparation of vaccine

  1980cited by this paper
• Characteristic residual neuropathological features of Japanese B encephalitis

  1977cited by this paper
• Japanese encephalitis purified vaccine. II. Purity of the mouse brain vaccine purified by ultracentrifugation.

  1970cited by this paper
• Studies on mouse brain and chick embryo tissue in connection with the preparation of Japanese encephalitis vaccine.

  1953cited by this paper
• International Journal of General Medicine

  year unknowncited by this paper

• Development and validation of an assay for detection of Japanese encephalitis virus specific antibody responses

  2020cites this paper
• Computer-Assisted and Data Driven Approaches for Surveillance, Drug Discovery, and Vaccine Design for the Zika Virus

  2019cites this paper
• Comparison of the adjuvanticity of two adjuvant formulations containing de-O-acylated lipooligosaccharide on Japanese encephalitis vaccine in mice

  2018cites this paper
• Comparison of the adjuvanticity of two adjuvant formulations containing de-O-acylated lipooligosaccharide on Japanese encephalitis vaccine in mice

  2017cites this paper
• Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010

  2016cites this paper
• Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China.

  2014cites this paper
• Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study.

  2012cites this paper
• Heterogeneous Nuclear Ribonucleoprotein A2 Participates in the Replication of Japanese Encephalitis Virus through an Interaction with Viral Proteins and RNA

  2011cites this paper